Hydroxyurea (HU) for prevention of recurrent stroke in sickle cell anemia (SCA).
about
Stroke in patients with sickle cell disease.How I treat and manage strokes in sickle cell disease.Therapeutic approaches and advances in pediatric strokeHydroxyurea for children with sickle cell diseaseThe prevention and management of stroke in sickle cell anaemia.Coagulation abnormalities of sickle cell disease: Relationship with clinical outcomes and the effect of disease modifying therapies.Role of hydroxycarbamide in prevention of complications in patients with sickle cell disease.Iron in sickle-cell disease: what have we learned over the years?Current concepts in the management of stroke in children with sickle cell disease.Clinicopathological and radiological study of Egyptian β-thalassemia intermedia and β-thalassemia major patients: relation to complications and response to therapy.Hydroxycarbamide treatment and brain MRI/MRA findings in children with sickle cell anaemia.Laboratory and Genetic Biomarkers Associated with Cerebral Blood Flow Velocity in Hemoglobin SC Disease.Long-term results using hydroxyurea/phlebotomy for reducing secondary stroke risk in children with sickle cell anemia and iron overload.Stroke recurrence in children with sickle cell disease treated with hydroxyurea following first clinical stroke.
P2860
Q30650303-5D44A1D8-0386-4386-838E-2A3F64BAB16CQ35743944-32F06D69-7E00-4314-9A46-DE8118B64904Q36428729-A4D98CFF-8B47-41AF-9CC1-812B2E5DF0F4Q36612962-263046CF-2EBD-47A3-8BD4-CB25B128138AQ36627220-66A0804C-CC4F-4C35-B103-23C4F5998A2BQ37033939-C3CE6F81-417D-4DDA-B928-7F01DC15DA4EQ37367662-B3463666-95DC-4947-BF38-A97860F4B016Q37820936-1A5FC24E-21FD-4232-8BDC-125652E19E19Q37831815-17EE872B-8348-49B4-BEC9-C86E6F5DAD92Q39260488-B08423C9-8B7C-4573-A77C-82018718C505Q39412777-9E08816A-8425-4CF6-8897-7FDFB49D74D3Q41169146-5E62C19E-6045-4F52-AFF1-22BB1C6F87A1Q42744561-CA03EB89-5CBE-437B-822E-0210CE721E76Q50180616-AC95EDC4-4190-4F9A-89F0-AB29B84DE7D9
P2860
Hydroxyurea (HU) for prevention of recurrent stroke in sickle cell anemia (SCA).
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Hydroxyurea (HU) for prevention of recurrent stroke in sickle cell anemia (SCA).
@ast
Hydroxyurea (HU) for prevention of recurrent stroke in sickle cell anemia (SCA).
@en
type
label
Hydroxyurea (HU) for prevention of recurrent stroke in sickle cell anemia (SCA).
@ast
Hydroxyurea (HU) for prevention of recurrent stroke in sickle cell anemia (SCA).
@en
prefLabel
Hydroxyurea (HU) for prevention of recurrent stroke in sickle cell anemia (SCA).
@ast
Hydroxyurea (HU) for prevention of recurrent stroke in sickle cell anemia (SCA).
@en
P2093
P2860
P356
P1476
Hydroxyurea (HU) for prevention of recurrent stroke in sickle cell anemia (SCA).
@en
P2093
Abraham Sumoza
David Sumoza
Renate de Bisotti
Virgil Fairbanks
P2860
P304
P356
10.1002/AJH.10205
P577
2002-11-01T00:00:00Z